A shadow market for unapproved slimming drugs is being driven by social media fitness personalities and vendors on messaging platforms, based on recent findings.
Experimental Drug Gaining Traction Online
Retatrutide, which is still in research studies, is being advertised by social media influencers for its alleged weight-reducing effects. Viewers are urged to contact these profiles directly for supplier links, while also obtaining discount codes.
Thriving Commerce on Messaging Platforms
Separately, a flourishing trade exists on messaging services, where groups with thousands of members share comparison photos, injection guides and assertions of next-day British shipping. Sellers promote the drug there before redirecting customers to other platforms for purchases.
Learning About The Experimental Drug
Retatrutide is an investigational injection created by US drugmaker Eli Lilly. The drug targets three intestinal hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Preliminary studies indicate it could assist individuals lose up to a quarter of their total weight. Referred to as the “triple G”, the substance is being promoted online as the successor to Ozempic.
Healthcare Experts Express Concerns
Nevertheless, physicians and chemists have cautions that the sale of what remains an unlicensed medication in the UK is a cause for concern and could result in individuals injecting products of unknown origin.
Some professionals stated the popularity for the experimental drug could be linked to the increasing price of approved slimming products such as Mounjaro.
Legal Status and Enforcement
Selling the unapproved drug on social media or messaging apps is illegal in the United Kingdom, as it is an unapproved drug that must not be marketed or supplied for personal consumption under the British medical regulations.
Several content creators attempt to sidestep the regulations by referring to the substance as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a restricted drug, but advertising and supply can still violate medicines, advertising, and consumer regulations, potentially leading to fines, legal action or prison.
Platform Response and Material Elimination
According to TikTok, the platform has taken down violative material and banned associated keywords and query recommendations. The organization stated it was dedicated to maintaining the platform secure and allocating resources in strengthening compliance measures.
Online Marketplace Activities
Research also discovered groups with up to 9,000 participants marketing retatrutide using Telegram's integrated discovery tool, which functions like a public directory. Typing “retatrutide” immediately displays groups with numerous of users, populated with photos of slimming results, positive testimonials and detailed instructions for mixing or administering at residence.
Within minutes of entering one group, a vendor posted contact information, where the majority of transactions occur. The vendor provided an instruction manual and guaranteed shipping within 48 hours. When questioned whether the product was authentic, one vendor said: “You can’t be sure.” Another provided a photo of a supposed testing documentation. None asked about body mass, health issues or previous experience.
Item Details and Pricing
Within these communities, messages show dark colored parcels with Royal Mail stickers, claiming to contain fresh supplies. One message stated: “It took eight of us to load them this morning.”
Customers can choose between powder vials, mixed at home with purified liquid, or ready-to-use injectors typically sold at £160 for 20mg. When asked how much time a pen should last, sellers give contradictory answers varying between a several days to “depends on your body”.
Platform Oversight and Safety Actions
A representative for Telegram said it regularly moderated harmful material on its service including material that encouraged the “misuse of controlled medications”. The company added that it removed “millions of pieces of harmful content each day”.
Medical Professional Warnings
“Individuals are injecting substances they can’t verify. Even if the science behind retatrutide is valid, these online products may not contain what they claim,” said a pharmacy expert, the head of pharmaceutical services at Chemist4U.
Dr Crystal Wyllie of Asda Online Doctor connected the surge in demand to recent price rises for approved slimming drugs such as Mounjaro. “With prices rising, patients are using online platforms. But fake injections are highly risky. You cannot know what’s inside or whether the environment they were made in was sterile,” she said.
Her staff has already seen patients harmed by personal administration from unverified sources. “We recognize the frustration, but purchasing from messaging apps or WhatsApp is taking chances with your well-being,” said the doctor. “These substances could be impure or improperly measured.”
Manufacturer Statement
A spokesperson from the pharmaceutical company said retatrutide was in third stage research studies and had not been evaluated or approved by any government authority globally. “Consequently at this point no one can market [it] for personal consumption,” they said, adding that any item “misleadingly claiming itself as a Lilly investigational product not yet approved … may expose patients to potentially significant medical dangers”.
